248 related articles for article (PubMed ID: 34439963)
1. Modeling Cardiomyopathies in a Dish: State-of-the-Art and Novel Perspectives on hiPSC-Derived Cardiomyocytes Maturation.
Lodola F; De Giusti VC; Maniezzi C; Martone D; Stadiotti I; Sommariva E; Maione AS
Biology (Basel); 2021 Jul; 10(8):. PubMed ID: 34439963
[TBL] [Abstract][Full Text] [Related]
2. A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes.
Ahmed RE; Anzai T; Chanthra N; Uosaki H
Front Cell Dev Biol; 2020; 8():178. PubMed ID: 32266260
[TBL] [Abstract][Full Text] [Related]
3. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
4. Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency.
Pioner JM; Santini L; Palandri C; Langione M; Grandinetti B; Querceto S; Martella D; Mazzantini C; Scellini B; Giammarino L; Lupi F; Mazzarotto F; Gowran A; Rovina D; Santoro R; Pompilio G; Tesi C; Parmeggiani C; Regnier M; Cerbai E; Mack DL; Poggesi C; Ferrantini C; Coppini R
Front Physiol; 2022; 13():1030920. PubMed ID: 36419836
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
[TBL] [Abstract][Full Text] [Related]
6. Development of appropriate fatty acid formulations to raise the contractility of constructed myocardial tissues.
Yoshida A; Sekine W; Homma J; Sekine H; Itoyama YY; Sasaki D; Matsuura K; Kobayashi E; Shimizu T
Regen Ther; 2022 Dec; 21():413-423. PubMed ID: 36248630
[TBL] [Abstract][Full Text] [Related]
7. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.
Biendarra-Tiegs SM; Clemens DJ; Secreto FJ; Nelson TJ
Stem Cells Dev; 2020 Jan; 29(2):75-89. PubMed ID: 31744402
[TBL] [Abstract][Full Text] [Related]
8. hiPSC Modeling of Inherited Cardiomyopathies.
Jung G; Bernstein D
Curr Treat Options Cardiovasc Med; 2014 Jul; 16(7):320. PubMed ID: 24838688
[TBL] [Abstract][Full Text] [Related]
9. Switch From Fetal to Adult
Veerman CC; Mengarelli I; Lodder EM; Kosmidis G; Bellin M; Zhang M; Dittmann S; Guan K; Wilde AAM; Schulze-Bahr E; Greber B; Bezzina CR; Verkerk AO
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739862
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell Transcriptomics of Engineered Cardiac Tissues From Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome.
Lam YY; Keung W; Chan CH; Geng L; Wong N; Brenière-Letuffe D; Li RA; Cheung YF
J Am Heart Assoc; 2020 Oct; 9(20):e016528. PubMed ID: 33059525
[TBL] [Abstract][Full Text] [Related]
11. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
12. Activation of AMPK Promotes Maturation of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells.
Ye L; Zhang X; Zhou Q; Tan B; Xu H; Yi Q; Yan L; Xie M; Zhang Y; Tian J; Zhu J
Front Cell Dev Biol; 2021; 9():644667. PubMed ID: 33768096
[TBL] [Abstract][Full Text] [Related]
13. Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes: Implications for disease modeling and maturation.
Ernst P; Bidwell PA; Dora M; Thomas DD; Kamdar F
Front Cell Dev Biol; 2022; 10():986107. PubMed ID: 36742199
[TBL] [Abstract][Full Text] [Related]
14. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
[TBL] [Abstract][Full Text] [Related]
15. Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes.
Ulmer BM; Stoehr A; Schulze ML; Patel S; Gucek M; Mannhardt I; Funcke S; Murphy E; Eschenhagen T; Hansen A
Stem Cell Reports; 2018 Mar; 10(3):834-847. PubMed ID: 29503093
[TBL] [Abstract][Full Text] [Related]
16. PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes.
Liu H; Sun Y; Xu H; Tan B; Yi Q; Tian J; Zhu J
Genes Dis; 2023 Sep; 10(5):2151-2166. PubMed ID: 37492732
[TBL] [Abstract][Full Text] [Related]
17. Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery.
Tani H; Tohyama S
Front Cell Dev Biol; 2022; 10():855763. PubMed ID: 35433691
[TBL] [Abstract][Full Text] [Related]
18. Structural Immaturity of Human iPSC-Derived Cardiomyocytes:
Koivumäki JT; Naumenko N; Tuomainen T; Takalo J; Oksanen M; Puttonen KA; Lehtonen Š; Kuusisto J; Laakso M; Koistinaho J; Tavi P
Front Physiol; 2018; 9():80. PubMed ID: 29467678
[No Abstract] [Full Text] [Related]
19. Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Pioner JM; Racca AW; Klaiman JM; Yang KC; Guan X; Pabon L; Muskheli V; Zaunbrecher R; Macadangdang J; Jeong MY; Mack DL; Childers MK; Kim DH; Tesi C; Poggesi C; Murry CE; Regnier M
Stem Cell Reports; 2016 Jun; 6(6):885-896. PubMed ID: 27161364
[TBL] [Abstract][Full Text] [Related]
20. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.
Pioner JM; Guan X; Klaiman JM; Racca AW; Pabon L; Muskheli V; Macadangdang J; Ferrantini C; Hoopmann MR; Moritz RL; Kim DH; Tesi C; Poggesi C; Murry CE; Childers MK; Mack DL; Regnier M
Cardiovasc Res; 2020 Feb; 116(2):368-382. PubMed ID: 31049579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
